KR3-28573-19496
3 vaccinations
11 coded responses
38 check-ins
11 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 928 / CA
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-11
Registered in v-safe
-
2021-02-13
Dose 1 — Moderna
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
-
2021-02-27
Survey response — day 14, dose 1MedDRA: Erythema, Feeling hot, Pruritus, Rash — Feeling: GoodFree text: Delayed rash on arm at injection site that spread down my arm. Rash was red, itchy, and hot. Rash first occurred about 5 or 6 days after injection.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
-
2021-03-13
Dose 2 — Moderna
-
2021-03-13
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-15
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Fair · Site: Pain, Redness, Itching · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-16
Survey response — days 1–6 daily, dose 2MedDRA: Injection site erythema, Injection site pruritus, Injection site rash — Feeling: Fair · Site: Redness, ItchingFree text: Rash, redness, and itching spreading from below injection site down to elbowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Survey response — days 1–6 daily, dose 2MedDRA: Injection site rash — Feeling: Fair · Site: Redness, Swelling, ItchingFree text: Rash spreading down from injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Fair · Site: Pain, Redness, Itching · Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-04-24
-
2021-06-12
Survey response — 3 months, dose 2MedDRA: Menstrual disorder — Feeling: GoodFree text: My menstrual cycle was off. It came twice in one month a month after my second shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-11
-
2022-03-05
Dose 3 — Pfizer-BioNTech
-
2022-03-08
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Vasodilatation — Feeling: Poor · Site: Pain, Itching · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Pain in the armpit on the same side as the injection site. Vein swelling on the chest.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-08
Report sent to call center — days 1–6 daily, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-03-09
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Rash, not including the immediate area around the injection siteFree text: Armpit painMedDRA releases: 2024-11 · check-in free text available
-
2022-03-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
- 2022-03-10
- 2022-03-11
- 2022-03-13
- 2022-03-20
- 2022-03-26
- 2022-04-02
- 2022-04-09
- 2022-04-16
- 2022-06-04
-
2022-09-03
Survey response — 6 months, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Molar pregnancy lossMedDRA releases: 2024-11 · check-in free text available
-
2022-09-03
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
-
2022-09-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-13 | Moderna | |
| 2 | 2021-03-13 | Moderna | |
| 3 | 2022-03-05 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-08 | Successful 2022-09-06 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-09-03 | Successful 2022-09-06 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 4 — day 14, dose 1
Symptoms: Delayed rash on arm at injection site that spread down my arm. Rash was red, itchy, and hot. Rash first occurred about 5 or 6 days after injection.
Release 5 — day 0, dose 2
Systemic reaction (other): No
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): Rash, redness, and itching spreading from below injection site down to elbow
Systemic reaction (other): Rash spreading down from injection
Systemic reaction (other): No
Release 9 — 3 months, dose 2
Symptoms: My menstrual cycle was off. It came twice in one month a month after my second shot.
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Pain in the armpit on the same side as the injection site. Vein swelling on the chest.
Systemic reaction (other): Armpit pain
Release 12 — 6 months, dose 3
Symptoms: Molar pregnancy loss
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Feeling hot | ✓ | ✓ | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Injection site rash | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Vasodilatation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release